Ancestim

Discover Ancestim, a G-CSF analog used to stimulate white blood cell production. Learn about its medical uses, dosage, side effects, and mechanism of actio

Ancestim Ancestim uses Ancestim side effects How Ancestim works granulocyte colony-stimulating factor neutropenia treatment white blood cell production Ancestim dosage immune system support
🏷 ATC Code: L03AA02 📂 Antineoplastic and immunomodulating agents, Immunostimulants, Colony stimulating factors, Granulocyte colony stimulating factor (G-CSF) 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Ancestim?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Ancestim?

Ancestim is an international nonproprietary name (INN) for a recombinant human granulocyte colony-stimulating factor (G-CSF) analog. It is a pharmaceutical agent designed to stimulate the production, maturation, and release of neutrophils, a crucial type of white blood cell, from the bone marrow into the bloodstream. By increasing the white blood cell count, Ancestim plays a vital role in strengthening the body's natural defenses and supporting the immune system, particularly in situations where it is compromised.

This medication is primarily used in the management of conditions characterized by low levels of neutrophils, a state known as neutropenia. Neutrophils are essential for fighting bacterial and fungal infections, making their adequate presence critical for overall health. Ancestim acts similarly to the natural G-CSF protein found in the human body, which is responsible for regulating the production of these specific immune cells.

How Does it Work?

The mechanism of action of Ancestim revolves around its ability to bind to specific G-CSF receptors located on the surface of hematopoietic stem cells and progenitor cells within the bone marrow. Once bound, Ancestim initiates a cascade of intracellular signaling pathways that promote the proliferation, differentiation, and activation of granulocyte precursor cells. This process accelerates their development into mature neutrophils.

Furthermore, Ancestim facilitates the release of these mature neutrophils from the bone marrow into the peripheral circulation. It also enhances the functional activity of existing neutrophils, improving their ability to migrate to sites of infection and effectively phagocytose (engulf) and destroy pathogens. By boosting both the quantity and quality of neutrophils, Ancestim helps to reduce the risk and severity of infections in patients with compromised immune systems.

Medical Uses

Ancestim's primary medical application is in the treatment and prevention of neutropenia. Its use is critical in several clinical scenarios:

  • Chemotherapy-Induced Neutropenia

    One of the most common applications is to reduce the incidence and duration of severe neutropenia in patients undergoing cytotoxic chemotherapy for non-myeloid malignancies. Chemotherapy agents often suppress bone marrow activity, leading to a drop in white blood cell counts and an increased risk of life-threatening infections. Ancestim helps to mitigate this side effect, allowing patients to complete their chemotherapy cycles more safely.

  • Bone Marrow Transplantation

    Ancestim is also used in patients receiving bone marrow or peripheral blood progenitor cell transplantation. It helps to accelerate neutrophil recovery following high-dose chemotherapy and/or total body irradiation, thereby shortening the period of immune vulnerability.

  • Severe Chronic Neutropenia

    For individuals suffering from congenital, cyclic, or idiopathic severe chronic neutropenia, Ancestim can be administered long-term to maintain adequate neutrophil levels and prevent recurrent infections.

  • HIV-Related Neutropenia

    In some cases, Ancestim may be used to treat neutropenia associated with HIV infection or its treatment, though other specific therapies for HIV are usually the primary focus.

Dosage

The dosage of Ancestim is highly individualized and depends on the specific medical condition being treated, the patient's body weight, and their response to therapy. It is typically administered via subcutaneous injection, meaning it is injected just under the skin. The frequency of administration can vary, often ranging from daily injections to several times a week, as determined by a healthcare professional.

For chemotherapy-induced neutropenia, Ancestim is usually started approximately 24 hours after the completion of chemotherapy and continued until the neutrophil count has recovered to an acceptable level. Patients and caregivers are usually trained on proper injection techniques if home administration is required. Adherence to the prescribed dosage and administration schedule is crucial for optimal therapeutic outcomes and to minimize potential risks.

Side Effects

Like all medications, Ancestim can cause side effects, although not everyone experiences them. The most common side effect is bone pain, which is usually mild to moderate and is attributed to the increased activity within the bone marrow as it produces new white blood cells. This pain can often be managed with over-the-counter pain relievers.

Other common side effects may include:

  • Headache
  • Nausea and vomiting
  • Fatigue
  • Injection site reactions (e.g., redness, swelling, bruising)
  • Muscle aches

Less common but more serious side effects can occur, such as allergic reactions, splenic rupture (a rare but potentially life-threatening condition, often indicated by left upper abdominal pain), and acute respiratory distress syndrome (ARDS). Patients should immediately report any severe or unusual symptoms to their doctor. Regular monitoring of blood counts is essential during Ancestim therapy to assess its effectiveness and detect any adverse reactions.

Drug Interactions

While Ancestim does not have a broad range of significant drug-drug interactions, there are a few considerations:

  • Chemotherapy Agents

    Ancestim should generally not be administered within 24 hours before or after cytotoxic chemotherapy. Administering it concurrently with chemotherapy could potentially exacerbate myelosuppression, as rapidly dividing cells are more susceptible to the effects of chemotherapy.

  • Lithium

    Lithium, a medication used to treat bipolar disorder, can sometimes potentiate the myeloproliferative effects of G-CSF, potentially leading to an exaggerated increase in neutrophil counts. Caution and close monitoring are advised if these drugs are used together.

  • Other Myelosuppressive Drugs

    The concurrent use of other drugs that can suppress bone marrow function should be carefully considered and monitored, as this could counteract the beneficial effects of Ancestim.

It is always crucial to inform your healthcare provider about all medications, supplements, and herbal products you are currently taking to avoid potential interactions.

FAQ

What is the main purpose of Ancestim?

The main purpose of Ancestim is to stimulate the production of white blood cells, specifically neutrophils, to treat or prevent neutropenia, a condition characterized by low neutrophil counts.

How is Ancestim administered?

Ancestim is typically administered via subcutaneous injection, meaning it is injected under the skin, often in the abdomen, thigh, or upper arm.

Is Ancestim a chemotherapy drug?

No, Ancestim is not a chemotherapy drug. It is a supportive care medication used to help the body recover from the effects of chemotherapy, particularly the reduction in white blood cell count.

What is neutropenia?

Neutropenia is a condition where there is an abnormally low number of neutrophils, a type of white blood cell, in the blood. This reduction increases a person's risk of developing serious infections.

Can Ancestim be used during pregnancy?

The use of Ancestim during pregnancy should be carefully considered. It should only be used if the potential benefit outweighs the potential risk to the fetus, and under strict medical supervision.

Products containing Ancestim are available through trusted online pharmacies. You can browse Ancestim-based medications at ShipperVIP or Medicenter.

Summary

Ancestim is a vital recombinant human granulocyte colony-stimulating factor (G-CSF) analog that plays a critical role in modern medicine. By effectively stimulating the production and release of neutrophils from the bone marrow, Ancestim helps to manage and prevent neutropenia, a condition that leaves patients vulnerable to severe infections. Its primary applications include mitigating chemotherapy-induced neutropenia, aiding in bone marrow transplantation recovery, and treating severe chronic neutropenia. While generally well-tolerated, common side effects like bone pain are manageable, and serious reactions are rare. Proper dosage, administration, and ongoing medical supervision are essential to maximize its therapeutic benefits and ensure patient safety, ultimately bolstering the body's natural defenses and improving patient outcomes in various clinical settings.